Mario Gabelli Merck & Co., Inc. Transaction History

Gamco Investors, Inc. Et Al

$9 Billion
Q3 2024

A detailed history of Mario Gabelli (Gamco Investors, Inc. Et Al) transactions in Merck & Co., Inc. stock. As of the latest transaction made, Gamco Investors, Inc. Et Al holds 80,943 shares of MRK stock, worth $8.14 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

80,943

Previous 76,771 5.43%

Holding current value

$8.14 Million

Previous $9.5 Million 3.29%

% of portfolio

0.1%

Previous 0.11%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$111.15 - $128.97 $463,717 - $538,062	4,172 Added 5.43%	80,943 $9.19 Million
Q2 2024 Aug 13, 2024	SELL	$123.8 - $132.96 $344,164 - $369,628	-2,780 Reduced 3.49%	76,771 $9.5 Million
Q1 2024 May 14, 2024	SELL	$113.24 - $131.95 $1.43 Million - $1.67 Million	-12,664 Reduced 13.73%	79,551 $10.5 Million
Q3 2023 Nov 08, 2023	SELL	$102.95 - $114.33 $3.05 Million - $3.38 Million	-29,580 Reduced 24.29%	92,215 $9.49 Million
Q2 2023 Aug 10, 2023	SELL	$108.61 - $118.38 $721,713 - $786,635	-6,645 Reduced 5.17%	121,795 $14.1 Million
Q1 2023 May 12, 2023	SELL	$102.94 - $114.86 $3.69 Million - $4.12 Million	-35,845 Reduced 21.82%	128,440 $13.7 Million
Q4 2022 Feb 13, 2023	SELL	$87.44 - $112.11 $751,984 - $964,146	-8,600 Reduced 4.97%	164,285 $18.2 Million
Q3 2022 Nov 10, 2022	SELL	$84.53 - $94.96 $231,612 - $260,190	-2,740 Reduced 1.56%	172,885 $14.9 Million
Q2 2022 Aug 12, 2022	SELL	$83.49 - $94.64 $161,803 - $183,412	-1,938 Reduced 1.09%	175,625 $16 Million
Q1 2022 May 18, 2022	SELL	$73.51 - $82.4 $40,430 - $45,320	-550 Reduced 0.31%	177,563 $14.6 Million
Q1 2022 May 13, 2022	BUY	$73.51 - $82.4 $86,741 - $97,232	1,180 Added 0.67%	178,113 $14.6 Million
Q4 2021 Feb 11, 2022	SELL	$72.28 - $90.54 $192,481 - $241,108	-2,663 Reduced 1.48%	176,933 $13.6 Million
Q3 2021 Nov 12, 2021	SELL	$71.68 - $78.83 $661,248 - $727,206	-9,225 Reduced 4.89%	179,596 $13.5 Million
Q2 2021 Aug 13, 2021	SELL	$70.31 - $77.77 $228,788 - $253,063	-3,254 Reduced 1.69%	188,821 $14.7 Million
Q1 2021 May 14, 2021	BUY	$68.86 - $81.11 $4.97 Million - $5.85 Million	72,178 Added 60.2%	192,075 $14.8 Million
Q4 2020 Feb 05, 2021	BUY	$71.77 - $79.65 $1.68 Million - $1.86 Million	23,373 Added 24.21%	119,897 $9.81 Million
Q3 2020 Nov 06, 2020	BUY	$73.18 - $82.95 $4.25 Million - $4.81 Million	58,034 Added 150.78%	96,524 $8.01 Million
Q2 2020 Aug 13, 2020	SELL	$70.42 - $80.13 $3.06 Million - $3.48 Million	-43,413 Reduced 53.01%	38,490 $2.98 Million
Q1 2020 May 14, 2020	BUY	$63.36 - $87.82 $472,792 - $655,312	7,462 Added 10.02%	81,903 $6.3 Million
Q4 2019 Feb 14, 2020	BUY	$77.58 - $87.54 $561,291 - $633,351	7,235 Added 10.77%	74,441 $6.77 Million
Q3 2019 Nov 01, 2019	SELL	$76.08 - $82.93 $308,124 - $335,866	-4,050 Reduced 5.68%	67,206 $5.66 Million
Q2 2019 Aug 02, 2019	SELL	$69.84 - $81.59 $2.28 Million - $2.67 Million	-32,685 Reduced 31.45%	71,256 $5.98 Million
Q1 2019 May 02, 2019	SELL	$69.58 - $79.36 $163,513 - $186,496	-2,350 Reduced 2.21%	103,941 $8.65 Million
Q4 2018 Jan 30, 2019	SELL	$65.24 - $75.71 $62,565 - $72,605	-959 Reduced 0.89%	106,291 $8.12 Million
Q3 2018 Nov 02, 2018	BUY	$57.69 - $67.84 $230,760 - $271,360	4,000 Added 3.87%	107,250 $7.61 Million
Q2 2018 Aug 10, 2018	SELL	$50.83 - $59.72 $229,192 - $269,277	-4,509 Reduced 4.18%	103,250 $6.27 Million
Q1 2018 May 09, 2018	BUY	$50.96 - $59.23 $2,904 - $3,376	57 Added 0.05%	107,759 $5.87 Million
Q4 2017 Feb 02, 2018	BUY	$51.62 - $61.64 $299,241 - $357,327	5,797 Added 5.69%	107,702 $6.06 Million
Q3 2017 Nov 01, 2017	BUY	$58.67 - $63.13 $5.98 Million - $6.43 Million	101,905	101,905 $6.53 Million

Others Institutions Holding MRK

# of Institutions

3,824

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $255B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track Mario Gabelli's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamco Investors, Inc. Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Gamco Investors, Inc. Et Al and Mario Gabelli with notifications on news.

Account